Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …

Premature ovarian insufficiency (POI) is the loss of normal ovarian function before the age of
40 years, a condition that affects approximately 1% of women under 40 years old and 0.1 …

Hormone therapy (HT) is an effective treatment for menopausal symptoms, including
vasomotor symptoms and genitourinary syndrome of menopause. Randomized trials also …

Infertility creates an immense impact on the psychosocial wellbeing of affected couples,
leading to poor quality of life. Infertility is now considered to be a global health issue …

Progressive loss of physiological integrity and accumulation of degenerative changes
leading to functional impairment and increased susceptibility to diseases are the main …

Ovarian age is classically considered the main cause of female reproductive infertility. In
women, the process proceeds as an ongoing decline in the primordial follicle stockpile and it …

Compared to embryonic and induced pluripotent stem cells, mesenchymal stem/stromal
cells (MSCs) have made their presence felt with good therapeutic promise and safety profile …

Premature ovarian failure (POF) is a common female reproductive disorder and
characterized by menopause, increased gonadotropin levels and estrogen deficiency before …

The ovary has a comparatively short functional lifespan compared with other organs, and
genetic and pathological injuries can further shorten its functional life. Thus, preserving …

Premature ovarian failure (POF) has become one of the main causes of infertility in women
of childbearing age and the incidence of POF is increasing year by year, seriously affecting …